Company intelligence / Profile preview

NextGen Genetics

Santa Clara, California, United States

Ownership: Private
Development stage: Commercial

Overview

NextGen Genetics was a leading provider of preimplantation genetic testing services in the U.S., specializing in advanced NGS-based diagnostics for IVF and reproductive health. The company joined the Luminary Life Sciences family in 2023 to form "Luminary Genetics," expanding its offerings and market reach. Its clinical results are characterized by high accuracy and reliability in detecting chromosomal abnormalities and monogenic disorders prior to embryo implantation.

Therapeutic areas: Women's Health
Modalities: Diagnostic testGenomic analysis
Industry: Molecular Diagnostics

Partnerships

Not specified; likely collaborates with fertility clinics and IVF centers.

Beyond the preview

Go deeper on NextGen Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NextGen Genetics.

Explore the full profile